This report looks at trends in the treatment of viral disease and delivers critical information to healthcare executives in order to gain competitive advantage in the marketplace.
As it evaluates strategies for taking advantage of new approaches to dealing with antiviral resistance issues, this innovation-oriented study takes a look at the likelihood, timing and the impact of the evolution of the antiviral marketplace.
